Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
Anti Viral UVC explores how ultraviolet light works and how UVC energy is an effective and environmentally friendly way to eradicate dangerous microorganisms in any environment.
When it comes to COVID-19 testing labs, size isn’t everything, according to Alan Thornhill, UK Country Manager at Igenomix and Honorary Professor of Reproductive Genetics at the University of Kent, who spoke to Natalie Broome (MSc student, Kent).
Simon Carter, Director at RM Education says that COVID-19 created deep-rooted education changes in the UK, and that we must now strengthen the world of online learning.
The Oxford and AstraZeneca vaccine trial gave an accidental half-dose to 3,000 people - but this mistake is the reason the vaccine acted as 90% efficient.
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, says this time is different and the TRIPS Council knows it - the COVID-19 vaccine needs to be freely accessible to all countries.
COVID-19 came from Wuhan, China, but the conditions that enabled the virus to jump from animal to human are not unique - so where could the next pandemic begin?
The impact of COVID in Myanmar can be measured in the vindictively fast onset of poverty - with one third of households earning no money for the month.
Prime Minister Boris Johnson yesterday (23 November) announced his UK winter plan to the House of Commons, proposing a mass community testing scheme, stricter Tiers, and weekly tests for prison staff.
Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.
